Enlight Biosciences, a pharma industry-backed entrepreneurial venture, unveiled its newest portfolio company today, Knode. The Cambridge, MA-based startup, which is developing a LinkedIn-like social networking tool for drug companies, has formed ...

By Ryan C. Dallavia. Former hedge fund manager, Stanley Druckenmiller, may not be picking stocks for the general public, but he's made big bets in his family trust that had $2.2 billion in its 13F portfolio.

Failure by the Federal Reserve to take any new steps to stimulate the U.S. economy sent stock prices lower Wednesday. The Dow Jones Industrial Average fell 37.62 points to 12971.06.

--Traders report unusual trading across dozens of stocks. --Knight Capital Group looks into technical issues with trading systems.

Pfizer Inc logo Pfizer (NYSE: PFE)'s stock had its �neutral� rating restated by Zacks in a research report issued to clients and investors on Wednesday.

By Andrew McDonald, Ph.D. and Ning Yang, Ph.D. SciClone Pharmaceutcials (SCLN) is a US-based, China-focused, pharmaceutical company uniquely positioned to take advantage of the growing Chinese pharmaceutical market.

Below is a look at some of the headlines for companies that made news in the healthcare sector on July 31, 2012. DepoMed, Inc. (Nasdaq: DEPO) announced it has submitted a New Drug Application (NDA) for Serada to the United States Food and Drug ...

Barclays maintains an 'Equalweight' on Pfizer (NYSE: PFE) price target of $22.00. Analyst, C. Anthony Butler, noted that PFE topped Q2 estimates by $0.08 on stronger-than-expected revenues...with emerging markets giving a big push. Looking into 2013 ...

Pfizer (NYS: PFE) reported earnings on July 31. Here are the numbers you need to know. The 10-second takeaway. For the quarter ended June 30 (Q2), Pfizer met expectations on revenues and beat expectations on earnings per share.

BP plc (ADR) (NYSE: BP ) posted second quarter earnings per share of $1.16, missing the Zacks Consensus Estimate of $1.46 � Pfizer Inc. (NYSE: PFE ) reported second quarter earnings per share of $0.62, higher than the Zacks Consensus Estimate of $0.55 ...